SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models
Zylkiewicz, E, Rzymski, T, Mikula, M, Dreas, A, Wiklik, K, Wrobel, A, Golas, A, Dolata, I, Wojcik, K, Masiejczyk, M, Statkiewicz, M, Kuklinska, U, Goryca, K, Grochowsk, A, Cabaj, A, Bialas, A, Mikulski, M, Windak, R, Ostrowski, J, Brzozka, K
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
402 - SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models
Zylkiewicz, E., Rzymski, T., Mikula, M., Dreas, A., Wiklik, K., Wrobel, A., Golas, A., Dolata, I., Wojcik, K., Masiejczyk, M., Statkiewicz, M., Kuklinska, U., Goryca, K., Grochowsk, A., Cabaj, A., Bialas, A., Mikulski, M., Windak, R., Ostrowski, J., Brzozka, K.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article